当前位置:
X-MOL 学术
›
J. Clin. Invest.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Response to Kunos et al. and Lotersztajn and Mallat
The Journal of Clinical Investigation ( IF 15.9 ) Pub Date : 2022 , DOI: 10.1172/jci156247 Simeng Wang 1 , Qingzhang Zhu 1 , Guosheng Liang 1, 2 , Tania Franks 3 , Magalie Boucher 3 , Kendra K Bence 4 , Mingjian Lu 4 , Carlos M Castorena 1 , Shangang Zhao 1 , Joel K Elmquist 1 , Philipp E Scherer 1 , Jay D Horton 1, 2
中文翻译:
对库诺斯等人的回应 以及洛特斯坦和马拉特
更新日期:2022-01-05
The Journal of Clinical Investigation ( IF 15.9 ) Pub Date : 2022 , DOI: 10.1172/jci156247 Simeng Wang 1 , Qingzhang Zhu 1 , Guosheng Liang 1, 2 , Tania Franks 3 , Magalie Boucher 3 , Kendra K Bence 4 , Mingjian Lu 4 , Carlos M Castorena 1 , Shangang Zhao 1 , Joel K Elmquist 1 , Philipp E Scherer 1 , Jay D Horton 1, 2
Affiliation
Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD
Simeng Wang, … , Philipp E. Scherer, Jay D. Horton Simeng Wang, … , Philipp E. Scherer, Jay D. Horton Research Article Hepatology Metabolism中文翻译:
对库诺斯等人的回应 以及洛特斯坦和马拉特